Latest Stem cells Stories
COMMERCIAL-SCALE PRESERVATION OF THERAPEUTICALLY-ACTIVE STEM CELL-DERIVED PRODUCTS FOR WORLDWIDE MARKETPLACE OPPORTUNITIES SAN DIEGO, March 24, 2015 /PRNewswire/ -- Stemedica Cell
HAIFA, Israel, March 24, 2015 /PRNewswire/ -- The stem cell company Accellta announced today that it has granted exclusive worldwide rights to STEMCELL Technologies Inc.
A new study appearing in STEM CELLS Translational Medicine has moved science one step closer to finding a simple treatment for erectile dysfunction (ED) after prostate cancer surgery, eschewing
At the upcoming 5th World Congress on Cell and Stem Cell Research, taking place in Chicago next week (March 23-25), Asymmetrex, LLC will lead the symposium on Stem Cell Medical Engineering.
32 company presentations and five expert-led sessions will cover the future outlook for the industry, commercialization and market access strategies, capital markets, gene therapy delivery and
Biotech Veteran Will Lead Clinical Development Efforts of Encapsulated Cell Therapy in Ophthalmology CUMBERLAND, R.I., March 18, 2015 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc.
HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 18, 2015 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.
TAIPEI, March 18, 2015 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") today announced the signing of an agreement to collaborate with Cellex GmbH and the University Hospital
LONDON, March 17, 2015 /PRNewswire/ -- Report DetailsStem cells, an expanding market with vast potential - explore developments and commercial prospectsWhat does the future
SAN DIEGO, March 17, 2015 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for the treatment of diabetes
- A woman chauffeur.
- A woman who operates an automobile.